Valuation Morepen Laboratories Limited

Stocks

Market Closed - Bombay S.E. 11:02:26 29/09/2026 BST			5-day change	1st Jan Change
118.80 ^INR	-1.49%		-0.13%	+189.26%

08-05	Morepen Laboratories Limited announces Annual dividend, payable on October 26, 2026	CI
08-04	Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	14,462	17,488	13,127	21,500	26,220	18,521
Change	-	20.93%	-24.94%	63.79%	21.95%	-29.36%
Enterprise Value (EV) ¹	15,415	18,663	13,162	21,620	26,219	20,059
Change	-	21.07%	-29.48%	64.27%	21.27%	-23.49%
P/E	15x	18.7x	33.4x	22.4x	21.8x	19.5x
PBR	3.4x	3.02x	1.74x	2.54x	2.27x	1.49x
PEG	-	-2.12x	-0.6x	0x	1.3x	-0.9x
Capitalization / Revenue	1.21x	1.12x	0.92x	1.26x	1.45x	1.03x
EV / Revenue	1.29x	1.2x	0.93x	1.27x	1.45x	1.11x
EV / EBITDA	12.5x	13.9x	19.2x	14x	16.2x	18.2x
EV / EBIT	15.7x	15.8x	23.5x	15.8x	18.1x	22.5x
EV / FCF	-54.9x	-13x	-47.9x	-94x	-11.8x	-13.5x
FCF Yield	-1.82%	-7.71%	-2.09%	-1.06%	-8.51%	-7.39%
Dividend per Share ²	-	-	-	-	0.2	0.2
Rate of return	-	-	-	-	0.42%	0.59%
EPS ²	2.15	1.96	0.77	1.88	2.2	1.731
Distribution rate	-	-	-	-	9.09%	11.6%
Net sales ¹	11,980	15,558	14,220	17,019	18,116	18,057
EBITDA ¹	1,230	1,338	686.6	1,545	1,620	1,101
EBIT ¹	981.7	1,180	560.8	1,366	1,451	891.9
Net income ¹	970.9	1,017	386.8	961.6	1,180	948.8
Net Debt ¹	953.1	1,174	34.98	120.5	-0.928	1,538
Reference price ²	32.15	36.60	25.68	42.06	47.85	33.80
Nbr of stocks (in thousands)	449,826	477,826	511,169	511,169	547,954	547,954
Announcement Date	04/09/21	02/09/22	04/09/23	01/08/24	12/08/25	01/09/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MOREPEN LABORATORIES LIMITED	-	-	-	-	688M
ELI LILLY AND COMPANY	33.68x	12.2x	24.79x	0.59%	1,056B
JOHNSON & JOHNSON	30.25x	6.73x	18.83x	1.97%	655B
ABBVIE INC.	33.7x	7.87x	16.27x	2.61%	471B
ROCHE HOLDING AG	19.34x	4.71x	11.68x	2.82%	342B
NOVARTIS AG	20.6x	5.35x	13.29x	2.98%	277B
ASTRAZENECA PLC	21.11x	4.38x	12.46x	2.02%	257B
AMGEN INC.	26.41x	6.87x	12.24x	2.41%	226B
GILEAD SCIENCES, INC.	-46.04x	6.69x	26.14x	2.16%	189B
NOVO NORDISK A/S	11.29x	4.12x	8.55x	4.45%	170B
Average	16.71x	6.55x	16.03x	2.45%	364.36B
Weighted average by Cap.	24.21x	7.89x	18.18x	1.96%